Capital Flow Monitor · Sponsors · CIK 1786949
Sparrow Pharmaceuticals, Inc.
1050 Southwest 6th Street, PORTLAND, OR, 97204 · 6174650328
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$121.4M
Sold
$61.8M
% sold
50.9%
Investors
17
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | D ·current | 506(b) | $121.4M | $61.8M | 50.9% | 17 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Robert Jacks — Executive Officer / Director, Portland, OR
- Niall O'Donnell — Director, Portland, OR
- Zach Scheiner — Director, Portland, OR
- Peter Thompson — Director, Portland, OR
- Klaus Veitinger — Director, Portland, OR
- Nanna L?neborg — Director, Portland, OR
- Jonathan Root — Director, Portland, OR
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.